EGFR and lung adenocarcinoma: Similarly, Sakuma et al. found that depletion of ATG5, an autophagy inhibitor, markedly reduces gefitinib-resistant cell viability of EGFR-mutated lung adenocarcinoma cells under hypoxic conditions36.